국가: 네덜란드
언어: 영어
출처: HMA (Heads of Medicines Agencies)
porcine reproductive and respiratory syndrome virus inactivated 2.5 log10 IF Units
BOEHRINGER INGELHEIM FRANCE
QI09AA05
Emulsion for injection
Porcine reproductive and respiratory syndrome (PRRS) virus
Pigs
2012-06-01
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ingelvac® PRRS KV emulsion for injection for pigs (sows and gilts) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Inactivated Porcine Reproductive and Respiratory Syndrome (PRRS) virus, P120 strain: 2.5 log10 IF* Units. *IF Units: ImmunoFluorescence antibody titre obtained after two injections in pigs under specific laboratory conditions. ADJUVANT: O/w oily excipient (containing hydrogenated polyisobutene as adjuvant): q.s. 1 dose of 2 ml. EXCIPIENTS: For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Emulsion for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (sows and gilts). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Reduction of the reproductive disorders caused by Porcine Reproductive and Respiratory Syndrome virus (European strain) in a contaminated environment: vaccination reduces the number of early farrowing and the number of still-births. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES In PRRS infected herds, viral infection is heterogeneous and varies over time. In such context, the implementation of a vaccination program is a tool to improve the reproductive parameters and may contribute to the disease control in conjunction with sanitary measures. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Vaccinate only healthy animals. Apply usual procedures for the handling of animals. SPE CIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANI 전체 문서 읽기